Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2026-07-01EMA Withdrawn: Mulpleo (previously Lusutrombopag Shionogi) (Lusutrombopag) — Shionogi B.V.
Mulpleo (lusutrombopag) has been withdrawn by Shionogi B.V. for thrombocytopenia.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion
This clinical trial evaluates the relationship between C1q binding to HLA antibodies (measured in a solid-phase immunoassay) and the clinica…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Baricitinib for Post-HSCT Persistent Thrombocytopenia [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating baricitinib for persistent thrombocytopenia after allogeneic hematopoietic stem cell transplantation; cu…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Apixaban in Thrombocytopenia [EARLY_Phase 1]
This is an early Phase 1 clinical trial update on apixaban in patients with thrombocytopenia, including Deep Vein Thrombosis and Pulmonary E…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Managed Access Programs for ETB115, Eltrombopag
Novartis reports that managed access programs for ETB115, the eltrombopag product, are available for treating thrombocytopenia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of MegaLT Injection for Treating Refractory Thrombocytopenia Following Radiotherapy, Chemotherapy, or Transplantation. [Phase 1]
A Phase 1 clinical trial evaluating the safety, efficacy, and pharmacokinetics of MegaLT Injection for treating refractory thrombocytopenia …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion
A clinical study is evaluating outcomes of prothrombin complex concentrate (PCC) versus recombinant activated factor VIIa for trauma-associa…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma [Phase 2]
A Phase 2 trial assessing romiplostim to treat chemotherapy-induced low platelet counts in patients with lymphoma has been completed.
-
EMA approval · 2026-04-08EMA Authorised: Doptelet (avatrombopag maleate) — Swedish Orphan Biovitrum AB (publ)
EMA authorised Doptelet (avatrombopag) for the treatment of thrombocytopenia in the European Union; decision date 22 May 2025. Marketing aut…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery. [Phase 2]
Phase 2 trial evaluating preoperative romiplostim to treat thrombocytopenia in patients undergoing cardiac surgery; currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Luspatercept for Clonal Cytopenias of Uncertain Significance [Phase 2]
The entry notes an ongoing Phase 2 trial of luspatercept for clonal cytopenias of uncertain significance (CCUS) and related cytopenias such …
-
FDA approval · 2026-03-16FDA Approved: ELTROMBOPAG — Original Application (Dr. Reddy's Laboratories Inc.,)
FDA approved eltrombopag from Dr. Reddy's Laboratories under an original application (ANDA219121).
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT [Phase 3]
Phase 3 study evaluating etamsylate to prevent bleeding versus placebo in patients undergoing hematopoietic stem cell transplantation; curre…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT) [Phase 2]
A Phase 2 clinical trial is evaluating the safety and efficacy of Umbilical Cord Blood Therapy for cancer treatment-induced thrombocytopenia…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia [Phase 2]
Phase 2 trial evaluating selinexor as monotherapy in patients with JAK inhibitor-naïve myelofibrosis and thrombocytopenia is currently recru…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Research for Plasma Biomarkers Associated With Fatigue in Thrombocytopenic Patients [NA]
A research study investigating plasma biomarkers linked to fatigue in patients with thrombocytopenia is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis [NA]
This clinical trial is investigating anti-platelet antibodies detected with the MAIPA assay to demonstrate the autoimmune nature of thromboc…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia [Phase 2, Phase 3]
Qilu Pharmaceutical's QL0911 is being studied in Phase 2 and Phase 3 trials for cancer treatment-induced thrombocytopenia. The study is curr…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis [Phase 4]
Phase 4 clinical trial update evaluating anticoagulation strategies in patients with cancer-associated thrombosis and thrombocytopenia, curr…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed State [NA]
Completed bioequivalence study of eltrombopag olamine tablets in healthy subjects under fed conditions. The study was conducted by Chia Tai …
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Herombopag Treated T-DM1 Induced Platelet Reduction [Phase 2]
A Phase 2 clinical trial is evaluating herombopag to treat thrombocytopenia induced by T-DM1, with recruitment ongoing.
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: The Phase III Clinical Study of Herombopag for the Treatment of Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery [Phase 3]
This update reports that the Phase 3 clinical study evaluating Herombopag for treating thrombocytopenia in chronic liver disease patients un…
-
CLINICAL_TRIALS trial_result · 2025-10-28Clinical Trial Update: TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia [Phase 3]
Phase 3 trial evaluating tranexamic acid therapy for bleeding in thrombocytopenia has completed and posted results.
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Platelet-Directed Whole Blood Transfusion Strategy for Malaria [NA]
This clinical trial update describes ongoing recruitment for a study evaluating a platelet-directed whole blood transfusion strategy for sev…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors [NA]
This clinical trials entry describes a multicenter, open-label randomized study evaluating Romiplostim N01 for chemotherapy- or chemoradioth…